Anti Microbial/Anti Fungal Tests Market
Anti-microbial/Anti-fungal Tests Market: Reference Laboratories Anticipated to be the Fastest Growing End User Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027
- 2017-11-09
- REP-GB-5566
- 268 pages
-
An Incisive, In-depth Analysis on the Anti Microbial Anti Fungal Tests Market
This study offers a comprehensive, 360 degree analysis on the Anti Microbial Anti Fungal Tests market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Anti Microbial Anti Fungal Tests market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
COVID -19 : Impact Analysis
Request the coronavirus impact analysis across industries and markets
Request Covid -19 ImpactLocal Governments Entering into Partnerships with Manufacturers in Anti-microbial/Anti-fungal Tests Market
Government partnerships and tendering between diagnostic kit manufacturers is poised to provide manufacturers with substantial long-term opportunities in the anti-microbial/ anti-fungal tests market. Governments in Latin American and Asian countries are working overtime to eradicate highly infectious diseases by providing free medication and diagnostic tests to their underprivileged citizens through government-backed programs. In order to achieve these objectives, local authorities need a constant supply of diagnostic kits and manufacture tendering or partnerships are the best solution to this. Partnership / tendering benefits manufacturers as it provides them with a stable revenue stream for a specific period of time. Emerging economies such as India and Brazil have favourable opportunities for tendering and this is expected to boost the anti-microbial/ anti-fungal tests market over the forecast period.
Companies Strengthening Distribution Channels to Target All End Users in Anti-microbial/Anti-fungal Tests Market
At present, companies in the anti-microbial/ anti-fungal tests market are investing in their distribution networks to increase their sales in untapped markets. An effective way to do so is through strategic partnerships and alliances with local suppliers. These partnerships have proven to be critically important to manufacturers because they provide an edge over the competition and allow companies to introduce their products into niche markets, increasing their user base. Hospitals are predicted to be the largest end-user in the global anti-microbial/ anti-fungal tests market for the foreseeable future and should push past US$ 1.2 billion by end 2027.
Lack of Innovation Culture a Challenge to Overcome in the Anti-microbial/Anti-Fungal Tests Market
Healthcare providers and medical personnel in general tend to be risk averse and extremely hesitant to change any policies or procedures. There have been several instances in the field of in-vitro diagnostics where physicians have been resistant to change if the impending innovation is likely to reduce the organizational income stream. The management and organization of diagnostic services can further exacerbate this problem. This constraint is felt even more acutely in emerging economies where innovations performed and maintained by well-funded labs do not work in resource-starved healthcare facilities in far-flung rural areas. Therefore, companies would do well to focus on the hospital segment of the APEJ anti-microbial/ anti-fungal tests market as it is anticipated to push past US$ 250 million in 2027.
Quality Education and Training Need of the Hour in the Anti-microbial/Anti-fungal Tests Market
For a seamless transition of molecular diagnostics from a lab to a clinic, extensive optimization is required to interpret the results accurately. Diagnostic and clinical labs need highly skilled professionals who are experts in the medical and healthcare field. Unfortunately, limited resources in emerging economies mean that they can allocate only a sliver of public funds to clinical labs and an even smaller percentage of this to quality assurance. Well-trained personnel are absolutely essential and are in short supply in the 21st century. A WHO report states that Sub-Saharan Africa has an acute healthcare crisis with only 168 medical schools in 47 countries. In Sub-Saharan Africa, 11 countries do not have a single medical school while 24 have only one. Although hospitals are the largest end-user in MEA anti-microbial/ anti-fungal tests market, the reference laboratory segment is projected to witness a higher CAGR of 5.6% from 2017 to 2027.
Future Market Insights offers an in-depth assessment of the global anti-microbial/anti-fungal tests market for the period 2017 to 2027. The report titled ‘Anti-microbial/Anti-fungal Tests Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027’ is a comprehensive study of the anti-microbial/anti-fungal tests market across different geographic regions with a global perspective. Leading companies actively involved in the anti-microbial/anti-fungal tests market have been analysed in the report. The market position and product portfolios have been mentioned to present an accurate picture of their present and future prospects in the anti-microbial/anti-fungal tests market. The revenues have been aggregated for a valuation of the anti-microbial/anti-fungal tests market for the historical period from 2012 to 2016. With the help of advanced formulas, the historical data is used as a reference point for estimating market size for the duration of the decadal study.
Anti-Microbial/Anti-Fungal Tests Market Taxonomy
|
Test Types |
End User |
Type |
Region |
|---|---|---|---|
|
|
|
|
Report Synopsis
To provide an outlook of the anti-microbial/anti-fungal tests market, the report includes an executive summary that touches on the regional aspects in the forecast period. The report delivers an unbiased and formal introduction to the anti-microbial/anti-fungal tests market by a clear-cut definition of both anti-microbial and anti-fungal tests as per industry parlance. The section has a summary of market values that are observed in through key metrics such as absolute dollar opportunity, CAGR, Y-o-Y growth rate, and revenue share percentage.
The report highlights several causative factors that impact the dynamics of the anti-microbial/anti-fungal tests market. Industry trends, macroeconomic factors, and market specific drivers, restraints, trends, and opportunities across all parameters are mentioned in the anti-microbial/anti-fungal tests market report. In addition to this, the intricate relationship between the pricing trends and cost structure is focused on in the anti-microbial/anti-fungal tests market report. Material sourcing strategies, distribution networks, and supply chain management insights are included in the report along with an intensity map clearly enunciating the market presence of companies across countries.
The report has dedicated sections for a segmental and sub-segmental evaluation of the anti-microbial/anti-fungal tests market. The anti-microbial/anti-fungal tests market has been segmented taking into account its wide scope in the healthcare industry. Company profiles for major stakeholders along with recent developments that influence the anti-microbial/anti-fungal tests market have been provided in the report. The section illustrates the current market position of the companies with adequate information on how they are devising long and short-term strategies to strengthen their position in the anti-microbial/anti-fungal tests market. Thus, this section can be immensely beneficial to incumbents as well as new entrants in the anti-microbial/anti-fungal tests market.
Perfectly Honed Research Methodology
The analysts at Future Market Insights have implemented a fool-proof, fact-based, and systematic methodology to prepare the anti-microbial/anti-fungal tests market report. Extensive primary and secondary research have allowed the team to gain a holistic view of the anti-microbial/anti-fungal tests market. Quantitative data has been seamlessly fused with qualitative insights with all the revenue figures in US dollars to cater to a global audience. The report objective is to allow market participants to exploit untapped opportunities as and when they arise and always stay one step ahead of the immediate competition.
Get in touch
Harish Tiwari
Global Head - Business Development
Akshay Godge
Client Partner - Global Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.